HoyleCohen’s iShares Biotechnology ETF IBB Stock Holding History

HoyleCohen’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$368K	Buy	+2,678	New	+$357K	0.03%	211

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

HoyleCohen's IBB Position: Q2 2024 in Review

HoyleCohen opened a new position in iShares Biotechnology ETF (IBB) in Q2 2024: 2,678 shares worth $368K. The stake represents 0.03% of the portfolio and ranks #211 among its holdings.

894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

HoyleCohen held 2,678 shares of iShares Biotechnology ETF worth $368K as of Q2 2024.
iShares Biotechnology ETF was a new HoyleCohen position in Q2 2024.
iShares Biotechnology ETF made up 0.03% of HoyleCohen's portfolio in Q2 2024, its #211 holding.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.